2018
Vasomotor symptom characteristics
Gray KE, Katon JG, LeBlanc ES, Woods NF, Bastian LA, Reiber GE, Weitlauf JC, Nelson KM, LaCroix AZ. Vasomotor symptom characteristics. Menopause The Journal Of The North American Menopause Society 2018, 25: 520-530. PMID: 29206771, PMCID: PMC5898980, DOI: 10.1097/gme.0000000000001033.Peer-Reviewed Original ResearchConceptsVasomotor symptomsDiabetes riskNight sweatsHazard ratioHot flashesWomen's Health Initiative participantsElevated diabetes riskConfidence intervalsProportional hazards modelIncident diabetesMetabolic riskPostmenopausal symptomsMenopause transitionMean durationSymptom characteristicsInitiative participantsSymptomsDiabetesRiskBehavior changeSeverityWomenDurationSweatAssociation
2015
The Association of Smoking and Acute Pancreatitis
Majumder S, Gierisch JM, Bastian LA. The Association of Smoking and Acute Pancreatitis. Pancreas 2015, 44: 540-546. PMID: 25872130, DOI: 10.1097/mpa.0000000000000301.Peer-Reviewed Original ResearchConceptsAcute pancreatitisRecurrent APCurrent smokersFormer smokersHazard ratioCigarette smokingRisk factorsSystematic reviewIndependent risk factorPooled hazard ratioAssociation of smokingRecurrent acute pancreatitisConfidence intervalsInvestigator reviewChronic pancreatitisSmoking statusCochrane DatabaseDatabase inceptionHigh riskSmokersDiscordant decisionsEligibility criteriaPancreatitisSmokingRisk
2004
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness.
Butterfield MI, Bosworth HB, Stechuchak KM, Frothingham R, Bastian LA, Meador KG, Swartz M, Horner RD. Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness. Journal Of The National Medical Association 2004, 96: 43-52. PMID: 14746353, PMCID: PMC2594764.Peer-Reviewed Original ResearchConceptsInjection drug useSevere mental illnessAfrican American veteransHepatitis BHepatitis CMental illnessRacial differencesRisk behaviorsRisk of HCVRisk of HBVAfrican American raceConfidence intervalsStrong risk indicatorSmoking crack cocaineMultiple sex partnersAfrican AmericansHigh rateHBV seroprevalenceHCV seroprevalenceHCV infectionMultivariable analysisPrevalence ratesPsychiatric unitHBVCaucasian veterans
1999
HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER
Nanda K, Bastian L, Hasselblad V, Simel D. HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER. Obstetrics And Gynecology 1999, 93: 880-888. DOI: 10.1097/00006250-199905001-00041.Peer-Reviewed Original ResearchHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen usersHormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstetrics And Gynecology 1999, 93: 880-8. PMID: 10912438, DOI: 10.1016/s0029-7844(98)00424-4.Peer-Reviewed Original ResearchConceptsHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen users
1998
Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Primary Care Update For OB/GYNS 1998, 5: 165. PMID: 10838309, DOI: 10.1016/s1068-607x(98)00064-x.Peer-Reviewed Original ResearchHormone replacement therapySummary relative riskRectal cancer incidenceHRT usersColon cancerReplacement therapyCancer incidenceRelative riskUse of HRTRisk estimatesPostmenopausal HRT usersRetrievable risk estimatesColorectal cancer incidenceAdjusted risk estimatesColon cancer mortalityRisk of deathMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language studiesTime of assessmentEstrogen usersHRT use